Similar Articles
A case of bullous pemphigus induced by L-dopa and dopamine agonist
Yonca Ünlübaş, Bekir Enes Demiryürek
DOI: 10.5606/phhb.dergisi.2022.7
The freezing phenomenon in Parkinson’s disease
Nazlı Durmaz Çelik, Serhat Özkan
DOI: 10.5606/phhb.dergisi.2022.1
Comparison of plasma homocysteine levels and frequency of polyneuropathy in idiopathic Parkinsonian patients with healthy controls
Mehmet Balal, Miray Erdem, Elif Banu Söker, Meltem Demirkıran
DOI: 10.5606/phhb.dergisi.2023.32
A case of Parkinsonism due to ventriculoperitoneal shunt overdrainage
Mehmet Balal, Miray Erdem, Elif Banu Söker
DOI: 10.5606/phhb.dergisi.2023.30
Rare case of pramipexole-induced hiccups
Dilek İşcan, Zehra Yavuz, Burcu Gökçe Çokal, Selim Selçuk Çomoğlu
DOI: 10.5606/phhb.dergisi.2024.25
Wearable technologies for monitoring symptoms in Parkinson’s disease
Deniz Küsbeci, Kaan Kurtoğlu, Ozge Yilmaz Küsbeci
DOI: 10.5606/phhb.dergisi.2024.43
Delayed neurological complication due to carbon monoxide intoxication: A case report of parkinsonism
Burcu Saadet Zeybek, Mehmet Balal
DOI: 10.5606/phhb.dergisi.2024.38
Secondary parkinsonism due to subdural hematoma: A case report
Asya Kosereisoglu, Banu Ozen Barut
DOI: 10.5606/phhb.dergisi.2024.31
Balancing motor control and psychiatric stability: A five-year experience with apomorphine infusion in Parkinson’s disease and bipolar disorder
Nilüfer Büyükkoyuncu Pekel, Demet Yıldız
DOI: 10.5606/phhb.dergisi.2025.40
New molecule in Parkinson’s disease treatment: Safinamide (monoamine oxidase-B plus inhibitor)
Murat Gültekin, Beyzanur Altıkulaç Ilikhan
DOI: 10.5606/phhb.dergisi.2025.49
A case of Parkinson’s disease with clinical deterioration specific to constipation periods
Funda Kaplan, Zehra Yavuz, Özlem Munis Bizpınar, Selim Selçuk Çomoğlu
DOI: 10.5606/phhb.dergisi.2025.33